United States· US:50090-6588_82287cb4-5de6-4470-ae7d-fa65e8b30c3a

Digoxin

A digoxin product containing digoxin, registered in United States by A-S Medication Solutions. The same ATC class is registered in 15 of our 19 countries.

ATC C01AA05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDigoxinATCC01AA05REGISTER NO.US:50090-6588_82287cb…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Digoxin is registered in 15 of 19 countries.

Countries holding a registration under ATC C01AA05 (digoxin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Digoxin · ATC C01AA05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of digoxin costs, country by country.

Normalised to the WHO defined daily dose (0.25 mg), the median price runs from $0.11 in France to $0.20 in United States — a ×1.8 gap.

  • United States: $0.20 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Digoxin · price per daily dose (0.25 mg)

USD · FX 28 Sept 2026

  • US United States$0.20 (acquisition cost)
  • FR France$0.11
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIGOXIN
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
C01AA05
ATC class
Digoxin
Defined daily dose
0.25 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    50090-6588-1
  • ndc11
    5009065881
    100 TABLET in 1 BOTTLE (50090-6588-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

473 interactions on record for digoxin.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Digoxin · interactions on record

473 records

  • 17 severe
  • 178 moderate
  • 48 minor
  • 182 info

Most severe, free to view

  • DolasetronA04AA04severe
  • Calcium gluconateA12AA03severe
  • Calcium chlorideA12AA07severe
  • Calcium glucoheptonateA12AA10severe

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Digoxin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All digoxin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Belgium · Lanoxin
  • Bulgaria · Дигоксин Софарма
  • Czechia · Digoxin Eneo, Digoxin Léčiva
  • Germany · Lanicor, Lanicor Ampullen
  • Denmark · Digoxin, Digoxin Dak
  • Estonia · Digoxin Eneo, Digoxin Grindeks
  • Spain · Digoxina Kern Pharma, Digoxina Teofarma
  • Finland · Digoxin Orion Mite, Orion
  • France · Digoxine Adultes Nativelle, Digoxine Arrow
  • United Kingdom (Northern Ireland) · Digoxin Accord, Digoxin Accord-Uk
  • Greece · Digoxin Anfarm, Digoxin Juvisé
  • Hungary · Digoxin Eneo, Digoxin Richter
  • Ireland · Lanoxin, Lanoxin Pg
  • Italy · Lanoxin
  • Lithuania · Digoxin Sopharma
  • Luxembourg · Lanoxin
  • Latvia · Digoxicor, Digoxin Grindeks
  • Malta · Digoxin Bristol Laboratories, Digoxin Sopharma
  • Netherlands · Lanoxin 125, Lanoxin 250
  • Norway · Digoxin Orifarm
  • Poland · Digoxin Teva, Digoxin Wzf
  • Portugal · Lanoxin, Lanoxin Md
  • Romania · Digoxin Zentiva, Digoxină Zentiva
  • Sweden · Digoxin Evolan
  • Slovakia · Digoxin Eneo, Digoxin Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4097f9c-181a-425b-bdf5-54b8c8eea71b
GET /v1/drugs/e4097f9c-181a-425b-bdf5-54b8c8eea71b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "DIGOXIN",
  "productndc": "50090-6588",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "ug/1",
  "application_number": "ANDA076363",
  "marketing_category": "ANDA"
}

See everything about digoxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.